
For a quarter-century, we’ve been driving innovation, fostering collaboration, and strengthening KC’s life sciences ecosystem. From advancing emerging technologies to accelerating world-class research, our region’s progress is a testament to the power of partnership.
Join us as we reflect on our journey, connect with industry leaders, and look ahead to the future of life sciences in Kansas City.
Details
Date: November 13, 2025
Location: The Midland Theatre
1228 Main St, Kansas City, MO
Parking: H&R Block
Enter between 13th St. and 14th St.
Attire: Business Formal
Agenda
5:30 PM | Networking & Science2Art Auction
6:30 PM | Dinner
7:30 PM | Program
8:00 PM | Science2Art Auction Closes
8:30 PM | Networking Resumes
9:30 PM | Adjourn
Science2Art
Science2Art is a platform for regional scientists to display their research through the visual arts. Each piece tells a personal research story.
All proceeds from the Science2Art auction will be donated to STEAM programs in our region.
View Artwork & Bid Now
Featured Speakers
Dedric Carter, PhD
Vice Chancellor for Innovation, Entrepreneurship and Economic Development and Chief Innovation Officer
The University of North Carolina at Chapel Hill
Dr. Dedric A. Carter is an experienced practitioner in innovation ecosystem strategy, execution, and technology-based economic impact creation. He serves as the Vice Chancellor for Innovation, Entrepreneurship and Economic Development and Chief Innovation Officer at the University of North Carolina at Chapel Hill. Dr. Carter has cabinet level responsibility for the entrepreneurship, innovation, economic development, and commercialization portfolios at the University through Innovate Carolina and the Innovate Carolina Junction (a new Hub for catalyzing innovation and accelerating entrepreneurial intention located in Chapel Hill, NC) among other oversight and engagement roles.
Nicholas Tatonetti, PhD, FACMI
Professor and Vice Chair of Operations
Department of Computational Biomedicine
Associate Director of Computational Oncology
Cancer Center at Cedars-Sinai Medical Center
Dr. Nicholas Tatonetti is Professor and Vice Chair of Operations in the Department of Computational Biomedicine and Associate Director of Computational Oncology in the Cancer Center at Cedars-Sinai Medical Center. They received a PhD from Stanford University where they focused on the development of novel statistical and computational methods for observational data mining. Over the past 14 years, Dr. Tatonetti has applied these methods to drug safety surveillance and the discovery of dangerous adverse drug effects and has identified and validated previously unknown serious drug-drug interactions.













